Literature DB >> 21536497

Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach.

Julie Lang1, Nicholas Weiss, Brian M Freed, Raul M Torres, Roberta Pelanda.   

Abstract

Hematopoietic humanized mice generated via transplantation of human hematopoietic stem cells (hHSCs) into immunodeficient mice are a valuable tool for studying development and function of the human immune system. This study was performed to generate a protocol that improves development and quality of humanized mice in the BALB/c-Rag2(null)Il2rγ(null) strain, testing route of injection, in vitro culture and freezing of hHSCs, types of cytokines in the culture, and co-injection of lineage-depleted CD34(-) cells. Specific hHSC culturing conditions and the addition of support cells were found to increase the frequency, and human hematopoietic chimerism, of humanized mice. The optimized protocol resulted in BALB/c-Rag2(null)Il2rγ(null) humanized mice displaying more consistent human hematopoietic and lymphoid engraftment. Thus, hematopoietic humanized mice generated on a BALB/c immunodeficient background represent a useful model to study the human immune system.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536497      PMCID: PMC3115423          DOI: 10.1016/j.clim.2011.04.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  46 in total

1.  Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.

Authors:  A C Ladd; R Pyatt; A Gothot; S Rice; J McMahel; C M Traycoff; E F Srour
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

3.  Phenotypic and functional reversal within the early human hematopoietic compartment.

Authors:  Shoshan Knaän-Shanzer; Ietje van der Velde-van Dijke; Marloes J M van de Watering; Philip J de Leeuw; Dinko Valerio; Dirk W van Bekkum; Antoine A F de Vries
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

4.  Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cells.

Authors:  Tamara Byk; Joy Kahn; Orit Kollet; Isabelle Petit; Sarit Samira; Shoham Shivtiel; Herzl Ben-Hur; Amnon Peled; Wanda Piacibello; Tsvee Lapidot
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

5.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice.

Authors:  O Kollet; R Aviram; J Chebath; H ben-Hur; A Nagler; L Shultz; M Revel; T Lapidot
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

7.  Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE.

Authors:  S-Y Joo; B-K Choi; M J Kang; D Y Jung; K S Park; J B Park; G S Choi; J Joh; C H Kwon; G O Jung; S K Lee; S-J Kim
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

8.  Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.

Authors:  Christin M Lepus; Thomas F Gibson; Scott A Gerber; Ivana Kawikova; Marian Szczepanik; Jaber Hossain; Vitaly Ablamunits; Nancy Kirkiles-Smith; Kevan C Herold; Ruben O Donis; Alfred L Bothwell; Jordan S Pober; Martha J Harding
Journal:  Hum Immunol       Date:  2009-06-12       Impact factor: 2.850

9.  Humanized mice: are we there yet?

Authors:  Francesca Macchiarini; Markus G Manz; A Karolina Palucka; Leonard D Shultz
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

10.  T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells.

Authors:  Ferenc A Scheeren; Maho Nagasawa; Kees Weijer; Tom Cupedo; Jörg Kirberg; Nicolas Legrand; Hergen Spits
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

View more
  20 in total

Review 1.  Humanized mice for immune checkpoint blockade in human solid tumors.

Authors:  Henry Yip; Carl Haupt; Grace Maresh; Xin Zhang; Li Li
Journal:  Am J Clin Exp Urol       Date:  2019-10-15

2.  Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

Authors:  Tanuja L Gutti; Jaclyn S Knibbe; Edward Makarov; Jinjin Zhang; Govardhana R Yannam; Santhi Gorantla; Yimin Sun; David F Mercer; Hiroshi Suemizu; James L Wisecarver; Natalia A Osna; Tatiana K Bronich; Larisa Y Poluektova
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

3.  Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice.

Authors:  Julie Lang; Bicheng Zhang; Margot Kelly; Jacob N Peterson; Jacob Barbee; Brian M Freed; James P Di Santo; Jennifer L Matsuda; Raul M Torres; Roberta Pelanda
Journal:  Blood Adv       Date:  2017-12-19

Review 4.  The cell-line-derived subcutaneous tumor model in preclinical cancer research.

Authors:  Stephen M Stribbling; Anderson J Ryan
Journal:  Nat Protoc       Date:  2022-07-20       Impact factor: 17.021

5.  Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation.

Authors:  Julie Lang; Margot Kelly; Brian M Freed; Martin D McCarter; Ross M Kedl; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

6.  Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.

Authors:  Carrie B Coleman; Julie Lang; Lydia A Sweet; Nicholas A Smith; Brian M Freed; Zenggang Pan; Bradley Haverkos; Roberta Pelanda; Rosemary Rochford
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 7.  The future potential for cocaine vaccines.

Authors:  Frank M Orson; Rongfu Wang; Stephen Brimijoin; Berma M Kinsey; Rana Ak Singh; Muthu Ramakrishnan; Helen Y Wang; Thomas R Kosten
Journal:  Expert Opin Biol Ther       Date:  2014-05-16       Impact factor: 4.388

8.  Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.

Authors:  Julie Lang; Anna Capasso; Kimberly R Jordan; Jena D French; Adwitiya Kar; Stacey M Bagby; Jacob Barbee; Betelehem W Yacob; Lia S Head; Kenneth D Tompkins; Brian M Freed; Hilary Somerset; Toshimasa J Clark; Todd M Pitts; Wells A Messersmith; S Gail Eckhardt; Margaret E Wierman; Stephen Leong; Katja Kiseljak-Vassiliades
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

9.  Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-mice.

Authors:  Thiago Alves da Costa; Jacob N Peterson; Julie Lang; Jeremy Shulman; Xiayuan Liang; Brian M Freed; Susan A Boackle; Pilar Lauzurica; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

Review 10.  The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.

Authors:  Bradford K Berges; Mark R Rowan
Journal:  Retrovirology       Date:  2011-08-11       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.